Navigation Links
GP Strategies Shareholders Approve Elimination of Holding Company Structure and Renaming of General Physics Corporation
Date:12/15/2011

ELKRIDGE, Md., Dec. 15, 2011 /PRNewswire/ -- GP Strategies Corporation (NYSE: GPX), announced today that its shareholders approved the merger of GP Strategies Corporation with and into its wholly-owned subsidiary, General Physics Corporation, eliminating the current holding company structure. General Physics, which is the sole operating subsidiary of GP Strategies, will be the surviving legal corporation and will be renamed GP Strategies Corporation when the merger becomes effective, which is expected to be on or before January 1, 2012. Following the merger, the financial position, business operations, state of incorporation, directors, executive officers and management of the newly combined company will be substantially identical to those of GP Strategies before the merger. GP Strategies will continue to be listed on the New York Stock Exchange under the ticker symbol GPX. Each share of GP Strategies common stock will automatically be converted into an equivalent number of shares in the surviving company. Holders of common stock will not be required to surrender their share certificates for purposes of the merger, and new certificates will not be issued in connection with the merger.

(Logo: http://photos.prnewswire.com/prnh/20110404/MM77341LOGO-a )

Scott N. Greenberg, Chief Executive Officer of GP Strategies, commented, "The elimination of the current holding company structure should simplify corporate administration, reduce certain expenses, and result in less confusion among investors, customers, suppliers and others regarding the relationship between GP Strategies and General Physics. General Physics got its start in the 1960's providing training for the U.S. nuclear energy industry.  Since then, General Physics has grown both organically and through acquisition of complementary businesses, increasing its geographic reach and expanding its service offerings to a wide variety of market sectors. With 'GP' in our name, the legacy of General Physics Corporation will continue. The name change to GP Strategies is an integral part of our decision to brand, under one name, several of the companies that have become part of the GP family as a result of our acquisition strategy."

About GP Strategies
GP Strategies, a NYSE-listed company (GPX), is a global performance improvement solutions provider of sales and technical training, e-Learning solutions, management consulting and engineering services. GP Strategies' solutions improve the effectiveness of organizations by delivering innovative and superior training, consulting and business improvement services, customized to meet the specific needs of its clients. Clients include Fortune 500 companies, manufacturing, process and energy industries, and other commercial and government customers. Additional information may be found at www.gpworldwide.com.

We make statements in this press release that are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934.  These statements reflect our current expectations concerning future events and results.  We use words such as "expect," "intend," "believe," "may," "should," "could," "anticipates," and similar expressions to identify forward-looking statements, but their absence does not mean a statement is not forward-looking.  These statements are not guarantees of our future performance and are subject to risks, uncertainties, and other important factors that could cause our actual performance or achievements to be materially different from those we project.  For a full discussion of these risks, uncertainties, and factors, we encourage you to read our documents on file with the Securities and Exchange Commission, including those set forth in our periodic reports under the forward-looking statements and risk factors sections.  Except as required by law, we do not intend to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

 


'/>"/>
SOURCE GP Strategies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Utilizing Public Relation Strategies During Pharmaceutical Lifecycle Management for Greatest Impact on Brand and Consumer Base
2. Studies Investigate New Methodologies to Improve Recovery and Survival Strategies for Patients Undergoing Hematopoietic Cell Transplantation
3. Successful Market Education Strategies and Tactics for New Pharmaceutical Product Launches in the Oncology Therapeutic Area
4. Global Diagnostic Imaging Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
5. Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
6. GP Strategies Corporation to Report Third Quarter 2011 Results on November 3, 2011
7. Groundbreaking Treatments, Innovative Prevention Strategies and New Insights on Impact of Lifestyle Factors on Digestive Health Presented at the American College of Gastroenterologys 76th Annual Meeting
8. Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar
9. Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015
10. Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success
11. Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... PARIS , April 20, 2017 ... EyeCET platform, the first non-viral gene expression technology that ... in the eye to address a wide range of ... UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... ...
(Date:4/20/2017)... Research and Markets has announced the ... Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market ... Low drug registration cost in Latin American countries and ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... , ... Rob Lowe is a popular actor that has been in many ... educational purpose as the host of the “Informed” series. The program focuses on many ... the series focuses on thyroid cancer. , Although thyroid cancer is an uncommon type ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... Economics Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking analysis ... (IRR) field. Offering practical takeaways to apply immediately to IRR programs, the report ...
(Date:4/27/2017)... ... April 27, 2017 , ... Last night, Christine Collins of ... Year for her extraordinary compassion and lifelong dedication to serve others. Since 1997, ... for the prestigious award each year – identifying a CAREGiver who has exemplified ...
(Date:4/27/2017)... , ... April 27, 2017 , ... Are you investing ... spike in water-related accidents and drownings during the summer. While most of us assume ... these situations occur every day. Very few people are taking the time to learn ...
(Date:4/26/2017)... ... ... Journal of Oral Implantology – Tooth loss is not simply an ... complications with speech, eating, and overcompensation of mouth due to the deficiency. To combat ... number of tooth replacements increase, it is imperative to design an implant that will ...
Breaking Medicine News(10 mins):